CG
MBIO icon

CFO4Life Group’s Mustang Bio MBIO Stock Holding History

CFO4Life Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Buy
33,510
+13,049
+64% +$9.27K ﹤0.01% 236
2026
Q1 		$14.9K Buy
20,461
+7,500
+58% +$7.06K ﹤0.01% 208
2025
Q4 		$12.7K Buy
12,961
+2,500
+24% +$3.3K ﹤0.01% 240
2025
Q3 		$15.9K Buy
+10,461
New +$18.6K ﹤0.01% 233

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CFO4Life Group's MBIO Position: Q2 2026 in Review

CFO4Life Group increased its Mustang Bio (MBIO) stake by 64% in Q2 2026, buying an estimated $9.27K and bringing the position to 33,510 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

CFO4Life Group first reported a position in MBIO in Q3 2025 and has held it in 4 quarters since. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • CFO4Life Group held 33,510 shares of Mustang Bio worth $23.5K as of Q2 2026.
  • CFO4Life Group bought 13,049 Mustang Bio shares in Q2 2026, an estimated $9.27K.
  • Mustang Bio made up ﹤0.01% of CFO4Life Group's portfolio in Q2 2026, its #236 holding.
  • CFO4Life Group first reported a position in Mustang Bio in Q3 2025 and has held it in 4 quarters since.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.